Investment Pitches

Pitch Summary:
AOD offers a significantly higher market yield compared to AGD, despite having virtually the same portfolio and NAV performance. The fund is undervalued with a market price discount, making it an attractive investment for institutional investors seeking higher income.

BSD Analysis:
AOD is trading at a -5.7% market price discount while AGD trades at a +16.6% premium, despite both funds having similar NAV performances. AOD's higher yield of +12.6% compared to AGD's +9.7% is appealing, especially for institutional investors who can benefit from the fund's liquidity and size. The market forces are likely to drive a shift from AGD to AOD as investors seek better returns without additional NAV risk. The fund's undervaluation presents an opportunity for significant income gains.

Pitch Summary:
The VanEck Africa Index ETF (AFK) is positioned to capitalize on the underowned and underinvested African markets, which have shown significant growth potential despite years of underperformance.

BSD Analysis:
AFK has demonstrated strong performance, rising over 57% year-to-date in 2025. The ETF benefits from a diversified portfolio, with significant allocations in materials and financials sectors, and a major focus on South African and Moroccan stocks. The technical indicators are favorable, with the 50-day moving average providing support and increasing trading volume. The ETF's strategy of focusing on companies with substantial African operations positions it well to benefit from the continent's economic growth. However, investors are advised to conduct thorough due diligence due to the inherent risks in emerging markets.

Pitch Summary:
AeroVironment has transformed into a full-fledged defense company following its acquisition of BlueHalo, positioning itself well in the growing drone and drone defense market. The company's recent developments in laser technology and AI-powered systems, along with a strong revenue growth and backlog, indicate significant potential for future growth.

BSD Analysis:
AeroVironment's acquisition of BlueHalo has significantly expanded its capabilities, making it a more comprehensive defense company. The company's revenue has surged, largely due to the acquisition, and it has a substantial backlog that promises future revenue growth. However, the integration of BlueHalo has also led to increased expenses and a decline in gross margins, which are expected to recover. The valuation is currently high, reflecting strong market momentum, but this could pose a risk if the company's execution on new contracts and margin recovery does not meet expectations. The demand for drone defense technology is expected to rise, driven by geopolitical tensions and the need for cost-effective defense solutions.

Pitch Summary:
A. O. Smith is positioned to capitalize on the growing demand for clean water solutions, driven by its strong market presence and innovative product offerings. The company benefits from a robust dividend growth history and a solid financial position, making it an attractive investment for long-term growth.

BSD Analysis:
A. O. Smith has demonstrated consistent revenue and earnings growth over the past decade, with a compound annual growth rate of 4.8% in revenue and 9.7% in earnings per share. The company's strategic focus on high-tech water heaters and water purification systems aligns with the increasing global demand for efficient water solutions. Despite near-term challenges such as tariff pressures and higher steel costs, A. O. Smith's long-term growth prospects remain strong, supported by its expansion into emerging markets and new product launches. The company's underleveraged balance sheet provides flexibility for strategic acquisitions, further enhancing its growth potential. With a dividend safety score of 99 and a potential undervaluation of 8%, A. O. Smith offers a compelling investment opportunity for dividend growth investors.

Pitch Summary:
Despite worsening financial metrics and ongoing litigation risks, Utah Medical Products, Inc. remains attractively priced with a strong balance sheet. However, due to continued revenue and profit declines, the recommendation is downgraded to 'hold'.

BSD Analysis:
Utah Medical Products has seen a 20.6% stock price drop due to weaker sales and litigation risks, but it has since risen by 21.7%. The company's fundamentals continue to worsen, with revenue and net income declining significantly. The litigation concerning its Filshie Clips remains a concern, although management does not foresee a material financial impact. The company's valuation remains attractive, especially considering its net cash position. However, the ongoing decline in financial performance warrants a cautious approach, leading to a 'hold' recommendation until further clarity on future prospects is available.

Pitch Summary:
Moody's Corporation is a solid investment due to its extensive moat, strong market position, and consistent revenue growth. However, current valuation suggests it is fairly priced, making it a 'HOLD' rather than a 'BUY'.

BSD Analysis:
Moody's operates in a shared oligopoly with significant barriers to entry, such as network effects and regulatory lock-in. The company's gross margins are impressive at 74%, and it maintains a stable free cash flow, which supports reinvestment and shareholder returns. Despite concerns about debt levels and asset turnover, Moody's financial health remains robust. Potential risks include regulatory scrutiny and technological disruption from AI advancements. The company's 3-year CAGR of revenue growth is 10.11%, aligning with its historical performance, but current market conditions suggest waiting for a more favorable entry point.

Pitch Summary:
Sony completed the spin-off of its financial arm, Sony Financial Group, on October 1, 2025. This move allows Sony to focus on its core electronics and entertainment businesses while enabling the financial arm to operate independently.

BSD Analysis:
The spin-off of Sony Financial Group from Sony marks a significant restructuring aimed at enhancing operational focus and unlocking value. By separating its financial services, Sony can concentrate on its strengths in electronics and entertainment, potentially driving innovation and growth in these areas. Meanwhile, Sony Financial Group can pursue its own strategic objectives as an independent entity. Despite the initial decline in share price post-listing, the spin-off could attract investors interested in distinct business models and growth trajectories. The move aligns with broader industry trends of conglomerates streamlining operations to enhance shareholder value.

Pitch Summary:
Honeywell plans to spin off Solstice Advanced Materials, which will focus on specialty materials with leading positions in refrigerants, semiconductor materials, protective fibers, and healthcare packaging solutions. This spin-off is expected to occur in Q4 2025 and could enhance shareholder value by creating a focused entity with strong market positions.

BSD Analysis:
The spin-off of Solstice Advanced Materials from Honeywell represents a strategic move to streamline operations and focus on core competencies. Solstice will emerge as a pure-play entity with leadership in high-growth markets such as refrigerants and semiconductor materials. This separation allows Honeywell to concentrate on its remaining businesses while providing Solstice with the agility to pursue targeted growth strategies. Additionally, Honeywell's partial ownership in Quantinuum, a quantum computing venture, adds an intriguing layer of potential future value. The spin-off could attract investors seeking exposure to specialty materials and advanced technologies.

Pitch Summary:
Vivani Medical plans to spin off Cortigent, its brain implant device business, by Q3 2025. This spin-off could unlock value by allowing Vivani to focus on its core business of miniature GLP-1 implants, while Cortigent pursues its own growth trajectory in the brain implant market.

BSD Analysis:
Vivani's decision to spin off Cortigent reflects a strategic focus on its core competencies while enabling Cortigent to independently pursue opportunities in the brain implant sector. The spin-off is supported by significant insider buying, indicating confidence in both Vivani's and Cortigent's prospects. Despite the postponement due to a government shutdown, the spin-off remains a compelling opportunity, with Cortigent poised to capitalize on its innovative brain implant technology. The separation could attract investors with distinct interests, potentially enhancing value for both entities.

Pitch Summary:
AnaptysBio plans to explore separating its business into two independent, publicly traded companies in 2026, which could unlock value by allowing the market to better assess the distinct fundamentals and valuations of its royalty business and clinical stage biotech unit.

BSD Analysis:
The separation of AnaptysBio's royalty business from its clinical stage biotech unit could lead to more accurate valuations for each segment, as they possess different risk profiles and growth potentials. The royalty business, Royaltyco, will manage rights to substantial royalties from GSK and Vanda, potentially providing a steady revenue stream. Meanwhile, the clinical stage biotech unit could attract investors interested in high-risk, high-reward opportunities. This strategic move may enhance shareholder value by catering to different investor preferences and improving operational focus.

Pitch Summary:
NVIDIA does not produce its own semiconductors—it designs them but outsources the manufacturing to Taiwan Semiconductor Manufacturing Company (TSMC)… crucial to TSMC’s business is its access to ASML Holding’s lithography machines, which are used to etch the ultra-fine features needed for modern processors. NVIDIA’s designs, TSMC’s manufacturing expertise, and ASML’s advanced lithography machines form the foundation of the current stock market boom.

BSD Analysis:
ASML is the single most critical company in semiconductor manufacturing — full stop. EUV demand is locked in for years, and High-NA EUV will widen the technology gap even further. No competitor exists, and none is coming. Every advanced chip — GPU, CPU, modem, AI accelerator — ultimately relies on ASML’s tools. Revenue visibility is incredible, margins elite, and geopolitical noise only increases ASML’s strategic importance. The stock looks expensive until you realize it’s a monopoly selling picks and shovels to the AI gold rush. ASML is the ultimate semiconductor bottleneck — and the ultimate winner.

Pitch Summary:
1. MSFT included among six megacaps driving the S&P 500
“Just six companies (NVIDIA, Microsoft, Apple, Alphabet, Amazon, and Meta)… account for more than a third of the entire value of the S&P 500.”

2. Microsoft’s extraordinary capex dependence on NVDA
“…Microsoft allocates 47% of its budgeted capital expenditure to Nvidia semiconductor chips.”

3. Included in megacap growth since ChatGPT launch
“…the six leading technology companies in the United States (NVDA, MSFT, AAPL, AMZN, META, GOOG) have increased their combined market value by $11.8 trillion.”

BSD Analysis:
Microsoft is embedding AI into the enterprise with a speed and depth nobody else can match. Azure’s hyperscaler strength plus OpenAI distribution creates a flywheel competitors can’t replicate. Copilot becomes an annuity as pricing formalizes and enterprise rollout accelerates. The balance sheet is pristine, margins exceptional, and regulatory noise manageable. Bears argue saturation; bulls point to AI-augmented workflows that touch every knowledge worker. This is a software empire absorbing AI into its bloodstream. A slam-dunk long-duration compounder.

Pitch Summary:
1. Page-long discussion of NVDA within the AI bubble narrative
“The most valuable and arguably the most important of these six leading companies is chip designer NVIDIA, whose advanced semiconductors form the basis of the United States’ dominance in AI. Access to the best semiconductors provides other U.S. technology companies a competitive advantage over international competitors, which in turn drives their combined market value ever higher. Importantly, NVIDIA does not produce its own semiconductors—it designs them but outsources the manufacturing to Taiwan Semiconductor Manufacturing Company (TSMC), the global leader in semiconductor foundry services. In turn, crucial to TSMC’s business is its access to ASML Holding’s lithography machines, which are used to etch the ultra-fine features needed for modern processors. NVIDIA’s designs, TSMC’s manufacturing expertise, and ASML’s advanced lithography machines form the foundation of the current stock market boom.”

2. NVDA’s dominance and capex exposure (Big Tech dependence)
“…Microsoft allocates 47% of its budgeted capital expenditure to Nvidia semiconductor chips. Additionally, Meta allocates 25%, Alphabet allocates 16%, Tesla allocates 13%, Amazon allocates 11%, and Apple is set to allocate 8%. The budget of these six companies combined represents 43% of Nvidia’s revenue. With a market value exceeding $4.5 trillion, comprising 8% of the S&P 500 Index, the hopes and dreams of many retail investors depend on Nvidia’s continued outperformance.”

3. NVDA named among the six stocks driving the S&P 500
“Just six companies (NVIDIA, Microsoft, Apple, Alphabet, Amazon, and Meta), with a combined market value exceeding $19 trillion, account for more than a third of the entire value of the S&P 500.”

4. NVDA benefiting from post–ChatGPT capital cycle
“Since the release of ChatGPT in 2022, the six leading technology companies in the United States (NVDA, MSFT, AAPL, AMZN, META, GOOG) have increased their combined market value by $11.8 trillion.”

5. Final remark — NVDA as the “projector” to avoid
“If ‘the essence of strategy is choosing what not to do,’ then the prudent investor chooses to sidestep the speculative allure of companies like Nvidia.”

BSD Analysis:
Nvidia doesn’t sell chips — it sells the future of scalable intelligence. Every model upgrade, every training race, every inference expansion pushes customers deeper into Nvidia’s ecosystem. Blackwell is a supercycle inside a supercycle. CUDA remains an iron moat, and NVLink ensures customers can’t mix and match architectures without pain. The only real question is how long demand stays vertical. The answer: longer than anyone wants to admit. Nvidia continues to be the gravitational center of AI.

Pitch Summary:
O’Reilly Automotive has been a Day 1 Right Tail holding and one of its best performers. The letter reviews the fund’s conviction-building process and ORLY’s durable competitive advantages. Amazon’s threat in 2017 created a buying opportunity as O’Reilly’s 50/50 split between DIY and DIFM customers, best-in-class distribution, and culture-driven service gave it structural advantages. The fund highlights ORLY’s superior reinvestment discipline, returning >30% ROIC and compounding capital through high returns. Even through disruptions like COVID and supply chain crises, O’Reilly executed better than peers, maintained margins, and extended its lead in professional repair markets.

BSD Analysis:
O’Reilly is one of the most consistent compounders in U.S. retail — pricing power, scale efficiency, and relentless execution drive elite margins. The DIY/ DIFM blend gives it resilience across cycles. EV penetration is a headwind only in theory; in practice, the parts mix adjusts slowly and predictably. Cash generation is monstrous, fueling constant buybacks. The market rarely misprices ORLY, but when it does, the window is brief. This is a defensive secular winner. A top-tier operator doing exactly what great operators do: compound quietly and relentlessly.

Pitch Summary:
Janus International is the dominant full-service solutions provider to the self-storage industry, with unrivaled scale, 80% institutional share, and ~50% total market share, enabling premium pricing, superior steel purchasing power, and deeply entrenched customer relationships. The market is fixated on the company’s recent cyclical drawdown—EBITDA falling ~45% peak-to-trough—yet this appears to represent a trough coinciding with the bottom of the self-storage and commercial construction cycle, not an impairment of Janus’ structural economics. Underlying demand drivers are stabilizing: housing turnover is at a 40-year per-capita low with early signs of reacceleration, REIT commentary points to improving mix-shift and move-in pricing, and international operations are inflecting with ~50% YoY growth in 1H25. With 20%+ through-cycle EBITDA margins, exceptionally high FCF conversion, and leverage now at a manageable ~2.3×, Janus is positioned to resume accretive capital allocation including opportunistic buybacks and bolt-on acquisitions. The company’s Noke smart-access platform provides underappreciated optionality, with ~409k units installed and high-margin recurring software revenue still in the early innings. At <9× trough EBITDA and a 9–10% trough FCF yield, the stock embeds muted expectations despite cyclical green shoots and clear catalysts for re-rating.

BSD Analysis:
Janus’ setup reflects a classic cyclical mispricing where a high-quality category leader is being valued as if structural earnings power has permanently deteriorated. The company retains an overwhelming competitive moat—national scale, one-stop shop capability, superior design engineering, and sole-source vendor relationships—that local competitors cannot replicate, especially in a capital-intensive environment with tight credit. As industry conditions improve, Janus should disproportionately benefit from pent-up R3 spending, rising self-storage transactions, and renewed new-build activity driven by lower rates and normalized housing turnover. Meanwhile, the commercial/industrial door business is becoming a meaningful second engine of growth, expanding Janus’ TAM and diversifying away from self-storage cyclicality. Noke could ultimately shift the revenue mix toward recurring software economics, structurally lifting margins and valuation multiples. Given strong cash generation, cleaned-up leverage, and a stock trading near trough multiples, Janus also screens as a credible private-equity takeout target if public markets fail to revalue the business.

Pitch Summary:
Waldencast is a distressed de-SPAC whose public valuation fails to reflect the meaningful strategic value of its two core beauty assets: Milk Makeup and Obagi. Despite messy financial reporting, an SEC investigation, tariff exposure, and inconsistent execution, both brands exhibit strong consumer resonance, high gross margins, and credible multi-year growth trajectories. At ~1.3–1.5× sales, the stock trades well below precedent beauty M&A multiples, where growing prestige brands routinely clear 3–5× revenues—and where ELF’s $1B acquisition of Rhode implies far higher private-market value for Waldencast’s portfolio. Management has now formally initiated a strategic alternatives process, and private buyers could extract substantial synergies, suggesting combined sale proceeds of $750M–$1B+, or ~$5–7/share. Even the sale of just one brand could delever the balance sheet and re-rate equity materially. The downside, while real, is likely bounded by ongoing revenue growth, normalized cash generation once one-timers abate, and brand equity that remains intact despite corporate noise.

BSD Analysis:
A classic busted-SPAC mispricing: public markets focus on restatements, late filings, leverage, and regulatory overhang, while private-market buyers anchor on the underlying economics of two high-margin, culturally relevant beauty brands with strong retail sell-through. Milk Makeup is showing accelerating U.S. momentum, expanding distribution, and social-media reach on par with much more highly valued peers. Obagi remains one of the fastest-growing professional skincare lines, benefiting from both U.S. derm adoption and accelerating international expansion. With 65–70% gross margins and $75M+ of potential sponsor-realizable EBITDA, the gap between trading value and acquisition value is unusually wide. While execution risk and SEC scrutiny create volatility, the ongoing strategic review sharply tilts the distribution toward an M&A outcome that crystallizes brand value far above current TEV.